$44.21
0.481.1%
At close: Aug 28, 5:00 PM EST
$44.21
0.481.1%
Pre-Market: 4:44 AM EST
Supernus Pharmaceuticals Inc Stock News
SUPNNASDAQ
Latest Supernus Pharmaceuticals Stock News | NASDAQ:SUPN | Benzinga
Get the latest news on Supernus Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Supernus Pharmaceuticals performance
Categories: All
Monday, August 17, 2026
Tuesday, August 04, 2026
Monday, August 03, 2026
- Supernus Pharma shares are trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.
- Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
- UPDATE: Supernus Pharmaceuticals Q2 Adj. EPS ...PRO
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Supernus Pharmaceuticals Q2 EPS $(1.01) Misse...PRO
- Supernus Pharmaceuticals To Merge With Indivi...PRO
